Dermata Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DRMA and other ETFs, options, and stocks.

About DRMA

Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. Its product pipeline includes DMT310, DMT400, and DMT410. 

CEO
Gerald T. Proehl
CEOGerald T. Proehl
Employees
8
Employees8
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2014
Founded2014
Employees
8
Employees8

DRMA Key Statistics

Market cap
4.55M
Market cap4.55M
Price-Earnings ratio
-0.09
Price-Earnings ratio-0.09
Dividend yield
Dividend yield
Average volume
152.94K
Average volume152.94K
High today
$0.80
High today$0.80
Low today
$0.6922
Low today$0.6922
Open price
$0.711
Open price$0.711
Volume
268.11K
Volume268.11K
52 Week high
$5.00
52 Week high$5.00
52 Week low
$0.5739
52 Week low$0.5739

People also own

Based on the portfolios of people who own DRMA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.